Depomed (DEPO) to Seek a Sale - Report
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Depomed (DEPO) Back in Play Amid Recent Chatter; Valuation Remains Below Horizon Offer - Mizuho
September 16, 2016 6:41 AM EDTMizuho securities affirms Depomed (Nasdaq: DEPO) at Buy with a price target of $23 following news that the company is seeking a possible sale.
The firm commented, We had previously modeled a hypothetical takeout price for DEPO of $26 based on a 4.5x EV/sales multiple applied to our FY:17 estimates of $558M. HZNP recently entered an agreement to acquire RPTP, an Orphan... More